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of ptosis and surgical treatment with frontalis suspension three years previously. Following complete ophthalmological examina-
tion and evaluation of the ptosis we carried out tarsal and fornix biopsy, which revealed accumulation of a weakly eosinophilic amy-
loid positive substance. We performed surgical correction using the levator aponeurosis–Müller’s muscle complex re-adaptation
technique and amyloid substance debulking in all the palpebral layers in the left eye. The material obtained was stained with hema-
toxylin–eosin, Congo Red, PAS and alpha-actin, which confirmed amyloid deposition. Successively, the right eye was operated in
the same manner and entropion was managed by dissection and removal of amyloid from subconjunctival layers. Five years fol-
lowing surgery, the corrective procedure for ptosis was still effective. Surgical treatment of ptosis is very complex and requires
precise indications. Appropriate management depends on the etiopathogenesis, accurate diagnosis, and clinical findings.
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Amyloidosis is a condition characterized by the deposition
of amorphous proteinaceous material in tissues. It is divided
into systemic or localized forms.1,2 Ocular and palpebral amy-
loidosis is a rare event and amyloid can be deposited in any
part of the orbit, globe, or adnexa.3–5
Clinical presentation of periocular or orbital amyloidosis is
variable depending on the deposited quantity and the tissues
involved. A common clinical sign is ptosis (54%) where the
degree of eyelid drooping is due to combination of ptosis
and pseudoptosis,3–7 the later being defined as a conditioncaused by a group of disorders that simulate ptosis without
the malfunction of the levator muscle.8
We report a rare case of bilateral localized amyloidosis
with ptosis treated using the levator aponeurosis–Müller’s
muscle complex re-adaptation technique9 and amyloid sub-
stance debulking in all the palpebral layers.
Case report
A 31-year-old woman presented with severe bilateral pto-
sis (Fig. 1) and she referred onset of the pathology nine years





Figure 1. Ptosis due to amyloidosis and results after surgery. Upper
image: frontal view before treatment; lower image: frontal view five years
after levator aponeurosis–Müller’s muscle complex advancement
treatment.
Figure 2. Histological staining of amyloid. Superior right: Congo-Red
staining detecting amyloid deposition; Inferior right: Congo-Red showing
apple-green birefringence in polarized light. Superior left: a-actin stain-
ing. Inferior left: PAS staining showing not abnormal deposition of
glycogen.
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means of blood tests and instrumental examination. The
medical history of the patient was negative for multiple mye-
loma or lymphoproliferative disorders. The family history was
negative. The patient referred frontalis suspension surgery
with silicone rods three years before. On presentation to
our unit, nine years after initial presentation, the patient pre-
sented eyelid and subcutaneous swelling and severe ptosis
with a palpebral fissure measurement of 4 mm and 3 mm in
the right and left eye, respectively. There was entropion of
the right eye. Levator muscle function was almost absent.
Lid eversion showed a conjunctival component of
amyloidosis. Slit lamp examination did not show other ocular
alterations and dilated fundus examination with ophthal-
moscopy was unremarkable in both eyes.
A tarsal and fornix biopsy in the left eye revealed accumu-
lation of a weakly eosinophilic amyloid positive substance.
Systemic investigations, including serum and urine protein
immunoelectrophoresis, showed no abnormality. The ptosis
in the left eye was surgically treated with local anesthesia;
the silicon rods were removed then through a cutaneous inci-
sion approximately 8 mm from the eyelid margin, an ellipse
of skin, subcutaneous and orbicularis oculi muscle was
removed, the levator aponeurosis–Müller’s muscle complex
was isolated and dissected, eight millimeters of the isolated
complex were then inserted into the anterior aspect of the
tarsal plate (measuring 4 mm over the latter), based on the
preoperative degree of ptosis and levator function. Meticu-
lous debulking of the semi-gelatinous substance, revealed
during dissection of each layer was performed (i.e. muscle,
subconjunctiva, subcutis). The material obtained was stained
with hematoxylin-eosin, Congo Red, PAS and alpha-actin.
Congo Red staining showed green birefringence, and amy-
loid deposition was confirmed (Fig. 2).
Two months later, the ptosis and lower-lid entropion in the
right eye worsened. The same technique was used to correct
the ptosis. Entropion was managed by dissection and
removal of the amyloid substance from the subconjunctival
layer without lateral canthoplasty.10In the examinations following surgery the down-up test in
both eyes showed a palpebral fissure measurement of 7 mm
in upward gaze, 6 mm in the primary position and 2 mm in
the downward gaze. Five years following surgery, the correc-
tive procedure for ptosis was still effective (Fig. 1).Discussion
Amyloidosis is a disease characterized by extracellular
deposition of a fibrillar proteinaceous insoluble material
due to abnormal production or a deficit of elimination of
these proteins.2,3
Local amyloidosis can be caused by deposition of mono-
clonal immunoglobulin light chains (j or k) usually by benign
B-cell or plasma cell clones.3–6 Periocular and ocular amyloi-
dosis is rare and unilateral forms are more frequent. The lar-
gest case series of ocular and periocular amyloidosis,
composed of 24 patients, was recently reported by
Liebovitch, where the mean age of patients was 57 ± 17 years
with a female to male ratio of 15:9.5
According to Liebovitch, ocular and periocular amyloido-
sis can be presented as a subconjunctival or subcutaneous
mass (95.8%), eyelid ptosis (54.2%), pain (25%), exophthal-
mos (21%), alteration in muscular activity (16.6%) and recur-
rent hemorrhage (12.5%).5
The symptoms vary according to extent of the disease and
the structures involved.
The time between onset and diagnosis of the disease has
been reported up to 11 years.5 Although the 31 year-old
female patient described herein was younger than patients
reported previously, and nine years had passed before diag-
nosis was made. Pseudoptosis was reported for the first time
by Uchida in 196211 and classified as a subgroup of ptosis by
Beard in 19698; it is a condition caused by a group of disor-
ders that simulate ptosis with the lowering of the eyelid but
without the malfunction of the levator muscle.8,11 In the pre-
sent case drooping of superior eyelid was due to the accumu-
lation of amyloid substance in all eyelid layers: subcutaneous,
subconjunctival, interstitial space of muscle, and Whitnall’s
ligament, thus, increasing the weight of the eyelid and creat-
ing a greater effort for the aponeurotic muscle complex.
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muscle and created adherence within Whitnall’s ligament and
the levator muscle aponeurosis exercising mechanical check.
Therefore, this case could be classified as ‘‘true ptosis’’ as
apposed to ‘‘pseudoptosis’’ since it was caused by both
mechanical accumulation of amyloid in the lid lamella and
malfunction of the levator muscle.
Management of ptosis can be a challenge. Myasthenia
must be ruled out. The paucity of local specific symptoms
in rare cases can lead to incorrect diagnosis. Magnetic reso-
nance imaging and computed tomography can be important
to localize orbital structures that are involved and to evaluate
the presence of amyloid material in muscular tissue.5,12
Furthermore, surgical treatment is very complex and requires
precise indications. Appropriate management depends on
the etiopathogenesis, accurate diagnosis, and clinical find-
ings. Frontalis suspension is indicated in cases of absent leva-
tor muscle functionality,13,14 and although it was not
indicated in this case of ptosis it had been performed as
the diagnosis of amyloidosis had not been made. Indeed,
management of ptosis in these cases is based on removal
of localized amyloid,4,5 levator muscle advancement, levator
resection,3 the Fasanella technique and, more rarely, tarsal
and conjunctival resection, combined with reconstruction of
the tarsus with conchal cartilage and levator muscle complex
reinsertion.
In the case reported herein two factors required consider-
ation: the mechanical component of the ptosis linked to the
presence of amorphous material in the lid lamella which can
interfere with a correct evaluation of levator muscle function-
ality, and involvement of the levator muscle complex.
Residual levator muscle functionality and the possibility of tis-
sue examination during surgery led us to choose the levator
aponeurosis–Müller’s muscle complex re-adaptation tech-
nique and amyloid substance debulking. Indeed, the
previous suspension technique, where tissues cannot be
examined during surgery, had not been successful. The
choice of the appropriate surgical procedure was, thus, con-
firmed by evaluation of levator functionality during surgery
performed in local anesthesia, and post-surgical testing.
Conclusions
In the present case the correction of ptosis using levator
aponeurosis–Müller’s muscle complex advancement and
reinsertion into the tarsus plate, yielded a good degree of
correction by providing improved levator muscle function
afforded by its release from the septal ligaments and its
advancement. Meticulous debulking of the amyloidsubstance that weakened the muscle and created adher-
ences within Whitnall’s ligament and the levator muscle
aponeurosis contributed to the good functional and esthetic
results obtained. Appropriate management of ptosis
depends on the etiopathogenesis, an accurate diagnosis,
and clinical findings. Amyloidosis of the levator muscle may
be a precursor to orbital amyloidosis; therefore, good
surgical results should not lead to complacency for careful
surveillance and regular follow-up of patients over time.
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